Menu
Search
Saturday, January 17, 2026

Creating liberating content

Email us
Subscribe
Menu
Search

AstraZeneca to Acquire EsoBiotec...

By engineering immune cells directly within the patient’s body, EsoBiotec is eliminating the barriers of traditional cell therapies and unlocking new possibilities for oncology and immune-mediated diseases.

Signal12 gears up for...

BOSTON, March 18, 2025: Signal12, a clinical-stage ophthalmic pharmaceutical company has announced the...

You've searched for: Sample

Uncategorized

Sample post title 0

Sample post no 0 excerpt.
Author name -
Uncategorized

Sample post title 1

Sample post no 1 excerpt.
Author name -
Uncategorized

Sample post title 2

Sample post no 2 excerpt.
Author name -
Uncategorized

Sample post title 3

Sample post no 3 excerpt.
Author name -
Uncategorized

Sample post title 4

Sample post no 4 excerpt.
Author name -
Uncategorized

Sample post title 5

Sample post no 5 excerpt.
Author name -
Uncategorized

Sample post title 6

Sample post no 6 excerpt.
Author name -
Uncategorized

Sample post title 7

Sample post no 7 excerpt.
Author name -
Uncategorized

Sample post title 8

Sample post no 8 excerpt.
Author name -
Uncategorized

Sample post title 9

Sample post no 9 excerpt.
Author name -
Uncategorized

Sample post title 10

Sample post no 10 excerpt.
Author name -
Uncategorized

Sample post title 11

Sample post no 11 excerpt.
Author name -

― Or explore...

AstraZeneca to Acquire EsoBiotec for $1B. Aims to advance cell therapy ambition

By engineering immune cells directly within the patient’s body, EsoBiotec is eliminating the barriers of traditional cell therapies and unlocking new possibilities for oncology and immune-mediated diseases.
Joseph George -

Signal12 gears up for phase 3 clinical trials for ocular graft-versus-host disease

BOSTON, March 18, 2025: Signal12, a clinical-stage ophthalmic pharmaceutical company has announced the alignment of its Phase 3 clinical trial strategy for Pro-ocular™ with the U.S. Food and Drug Administration (FDA). The novel drop-free therapy is poised to revolutionize...
Joseph George -
spot_img

Create a website from scratch

With Newspaper Theme you can drag and drop elements onto a page and customize them to perfection. Try it out today and create the perfect site to express yourself!

Buy Now ⟶

Enjoy exclusive access to our content

Get an online subscription and you can unlock any article you come across, getting instant emails when our site updates, too.

Subscribe today ⟶

Amsonia Menu

Categories to explore

BahrainBiopharmaBiotechCorporateEventsFeaturesGlobal

Contribute as an author

Who we are